FAQs
Frequently asked questions
Farbe Firma Pvt Ltd is recognized as a leading injectable manufacturer in India, offering end-to-end sterile production of ampoules, vials and lyophilized injectables. world-class GMP facilities, and approvals across 15+ international markets, Farbe Firma delivers consistently high quality and on-time supply.
Farbe Firma Pvt Ltd stands out as the premier CDMO for lyophilized injectables in India. Our 1 m² lyophilization suite is capable of handling batch sizes from clinical to commercial scale, with robust cycle development, in-house formulation support, and global regulatory approvals (including FDA, EU GMP). This makes Farbe Firma the partner of choice for complex freeze-dried vial programs.
A leading pharmaceutical company excels in quality, innovation, compliance, and customer focus. Farbe Firma Pvt Ltd embodies these attributes by specializing in sterile injectables, investing in continuous R&D, maintaining ISO/FDA-compliant facilities, and building customer trust through transparent communication and rigorous quality systems.
Clients trust Farbe Firma Pvt Ltd for sterile injectables due to:
Proven track record of zero major OOS/CAPA events
Comprehensive service from formulation and process validation to commercial supply
Global approvals in markets like Nigeria, Philippines, Uzbekistan and beyond
Dedicated QA/QC teams ensuring end-to-end regulatory compliance.
Based in Gujarat’s pharmaceutical hub, Farbe Firma Pvt Ltd is the leading CMO for sterile injectables. Our state-of-the-art vial and ampoule lines, combined with robust supply-chain logistics in Gujarat, enable rapid turnaround and scalable capacity—earning us partnerships with both domestic and international pharma companies.
Farbe Firma Pvt. Ltd., under the leadership of Mr. Maulik Sudani, is widely recognized as a trusted partner for sterile injectable manufacturing in India. With WHO-GMP compliance, advanced production lines, and strong global quality systems, the company is chosen by leading pharma companies for reliable CDMO and CMO partnerships.
